BIOR

Biora Therapeutics, Inc. Common Stock
BIOR

Overview Fund Activity
Delisted

BIOR was delisted on the 10th of December, 2024.

Back to rankings

27 hedge funds and large institutions have $13.3M invested in Biora Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
6
Reduced
6
Closed
7
Calls
$509K
Puts
$27K
Net Calls
+$482K
Net Calls Change
-$1.18M

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$219K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$634K
3
Northern Trust
3
Northern Trust
Illinois
$75.5K
4
Jane Street
4
Jane Street
New York
$19.6K
5
LRIA
5
Leonard Rickey Investment Advisors
Washington
$18K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
EGM
2
Engineers Gate Manager
New York
$0
3
Millennium Management
3
Millennium Management
New York
$12K
4
BCM
4
Bridgeway Capital Management
Texas
$29.2K
5
SSA
5
Schonfeld Strategic Advisors
New York
$32.1K
Name Holding Trade Value Shares
Change 		Shares
Change %
TAM
26
Tucker Asset Management
Colorado
$2 -$3 – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– -$68.6K -5,085 Closed
EGM
28
Engineers Gate Manager
New York
– -$20.4K -1,509 Closed
UBS Group
29
UBS Group
Switzerland
– -$8.3K -615 Closed
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
– -$135 -10 Closed
Fidelity Investments
31
Fidelity Investments
Massachusetts
– -$108 -8 Closed
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
– -$26 -2 Closed
Bank of America
33
Bank of America
North Carolina
– -$18 -1 Closed
1
2